COMMUNIQUÉS West-GlobeNewswire

RavenQuest Completes Non-Brokered Private Placement
28/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, June [...]
Tower One Provides Operational Update, Amends Existing Warrants and Issues New Warrants
28/06/2019
VANCOUVER, British Columbia, June 28, 2019 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE: TO) (OTCMKTS: TOWTF) (Frankfurt: A2DKQ4 ) (“Tower One” or the “Company ”) announces an operations update with the execution of [...]
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/06/2019
CAMBRIDGE, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Chr. Hansen Holding A/S - Major shareholder announcement from The Capital Group Companies, Inc.
28/06/2019
Company announcement No. 12/2019 June 28, 2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 [...]
Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets for the Treatment of Cystinuria
28/06/2019
Enteric-coated formulation offers flexible dosing options, including administration with or without food THIOLA EC expected to be available to patients next month SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- Retrophin, [...]
MRI Interventions, Inc. Announces Uplisting to NYSE American
28/06/2019
Stock Will Trade Under Its Existing Symbol ‘MRIC’ Starting July 3, 2019 IRVINE, Calif., June 28, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “ Company ”) today announced that its common stock has [...]
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/06/2019
CHICAGO, June 28, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
aTyr Pharma Announces Reverse Stock Split to Regain NASDAQ Compliance
28/06/2019
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today [...]
Cambium Networks Corporation Announces Closing of Initial Public Offering
28/06/2019
ROLLING MEADOWS, Ill., June 28, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”) (NASDAQ: CMBM), a provider of wireless broadband networking infrastructure solutions, today announced the closing of its [...]
Healthcare Special Opportunities Fund Announces June 2019 Quarterly Distribution
28/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 28, 2019 (GLOBE NEWSWIRE) -- ( TSX: MDS.UN ) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]
Biophytis Announces Results of 2019 Annual General Meeting of Shareholders
28/06/2019
All resolutions within the competence of the Ordinary General Meeting adopted Second notice to reconvene the Extraordinary General Meeting to be held in the coming weeks PARIS and CAMBRIDGE, Mass., June 28, 2019 (GLOBE [...]
Kiadis updates status of marketing authorization application for ATIR101
28/06/2019
Kiadis updates status of marketing authorization application for ATIR101 Amsterdam, The Netherlands, June 28, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical- [...]
Eurobio Scientific : compte-rendu de l’assemblée générale ordinaire et extraordinaire annuelle
28/06/2019
Compte-rendu de l’assemblée générale ordinaire et extraordinaire annuelle d’Eurobio Scientific Les actionnaires ont adopté toutes les résolutions à titre ordinaire et à titre extraordinaire Approbation de l’apport en [...]
BBS announces the subscription price of its ongoing share issue: 28,10 SEK
28/06/2019
BBS – Bioactive Bone Substitutes Oyj (“BBS or “Company”), an innovator in orthobiologics, announces that the subscription price per share in its ongoing share issue (the “Offering”) is 28,10 SEK. The subscription price [...]
Eko Unveils Algorithm to Assist in the Detection of Aortic Stenosis, a Valvular Heart Disease Affecting Over 3 Million People in the U.S.
28/06/2019
The investigational Aortic Stenosis (AS) algorithm, tested in partnership with Northwestern Memorial Hospital, can help quickly confirm suspected AS with a sensitivity of 97.2% and a specificity of 86.4% Berkeley, June [...]
Progenics Reiterates Targeted Directors’ Indispensable Experience and Leadership Critical to the Company’s Long-Term Success
28/06/2019
Comments on ISS Report Urges Shareholders to Vote “FOR” All of the Company’s Qualified Directors on the WHITE Proxy Card NEW YORK, June 28, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“ [...]
Saniona’s rights issue completed
28/06/2019
PRESS RELEASE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION [...]
Total number of shares and voting rights in Zealand Pharma at June 30, 2019
28/06/2019
Company announcement – No. 23 / 2019 Total number of shares and voting rights in Zealand Pharma at June 30, 2019 Copenhagen, June 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a [...]
New company takes over Certified Advisor role to OV
28/06/2019
Investor News Hoersholm, Denmark and Cambridge, MA, US, June 28, 2019. – Oncology Venture A/S (“OV” or the Company”) today announces that the Company will follow its main contact at its current Certified Advisor, [...]

Pages